Saturday, 25 July 2020

Coronavirus Drug Favipiravir To Be Sold Under Brand 'Ciplenza'

Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India to release Favipiravir in the country under the brand name ciplenza.


from Medindia Health News https://ift.tt/32UgUYP

No comments:

Post a Comment